Mie Holm Vilstrup
Papers
2
Total Citations
10
H-Index
2
About
Mie Holm Vilstrup is a clinical researcher whose work focuses on advancing the diagnosis and treatment of urological cancers, particularly prostate and renal cell carcinoma. She has made significant contributions to the use of functional imaging in cancer staging, most notably through a prospective proof-of-concept study on dual-time-point ¹⁸F-FDG-PET/CT in high-risk prostate cancer patients. This work, published in 2018, explored whether delayed image acquisition could improve preoperative staging accuracy for patients undergoing robot-assisted radical prostatectomy, laying groundwork for more precise surgical planning. In the realm of renal oncology, Vilstrup conducted a prospective study comparing renal functional outcomes after robot-assisted partial nephrectomy versus percutaneous cryoablation for clinical T1 renal cell carcinoma. Her 2023 findings provide critical insights into how baseline renal function influences post-treatment outcomes, helping guide treatment selection for patients with kidney tumors. Though her citation counts are still building, Vilstrup’s prospective, clinically focused studies represent important steps toward personalizing surgical and ablative therapies in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2